Myasthenia Gravis Infusion Treatment
AmeriPharma Specialty Care provides expert infusion therapy for patients with myasthenia gravis, offering personalized care, insurance coordination, and clinical monitoring to support long-term symptom management.




When Are Myasthenia Gravis Infusions Recommended?
Infusion therapy may be recommended for individuals with myasthenia gravis when oral medications alone do not provide sufficient symptom control or when the disease presents with moderate to severe symptoms. These advanced therapies are designed to target the underlying immune mechanisms contributing to muscle weakness and fatigue.
Patients who may benefit from myasthenia gravis infusion treatment include:
- Individuals with generalized myasthenia gravis (gMG)
- Patients who are acetylcholine receptor (AChR) or MuSK antibody-positive
- Those experiencing fremyasthenic crises
- Patients who have not responded adequately to first-line treatments
Your physician will carefully evaluate your diagnosis, antibody profile, symptom severity, and treatment history to determine whether infusion therapy is appropriate and to select the most effective treatment option for your individual needs.
FDA-Approved Infusion Therapies for Myasthenia Gravis
Efgartigimod alfa-fcab (Vyvgart®)
Efgartigimod alfa-fcab is a targeted FcRn inhibitor designed to reduce harmful immunoglobulin G (IgG) antibodies that contribute to myasthenia gravis symptoms. Treatment is administered in cycles, typically consisting of one intravenous infusion per week for four weeks. A subcutaneous formulation, Vyvgart Hytrulo®, is also available, offering an alternative administration option for eligible patients.
Eculizumab (Soliris®)
Eculizumab is a complement inhibitor that works by suppressing immune system activity that damages the neuromuscular junction. It is administered through regular intravenous infusions and is FDA-approved for adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis.
Ravulizumab-cwvz (Ultomiris®)
Ravulizumab-cwvz is a long-acting complement inhibitor with a similar mechanism of action to eculizumab but offers extended dosing intervals. After initial loading doses, ravulizumab-cwvz is administered via intravenous infusion every eight weeks, reducing the frequency of treatment while maintaining symptom control.
Rozanolixizumab-noli (Rystiggo®)
Rozanolixizumab-noli is a subcutaneous FcRn inhibitor approved for both AChR- and MuSK-antibody positive generalized myasthenia gravis. Its subcutaneous administration provides flexibility for patients who may prefer or require an alternative to traditional IV infusions.
Rituximab (Rituxan®)
Although not FDA-approved specifically for myasthenia gravis, rituximab is commonly used off-label, particularly in patients with MuSK-positive disease. This B-cell–depleting therapy has demonstrated strong potential for symptom improvement and long-term remission in select patient populations.
Get MG Infusion Care With AmeriPharma® Specialty Care

Proactive, Personalized MG Care
- Dedicated clinician assigned to oversee your care
- Ongoing monitoring and treatment adjustments
- Close coordination with your neurologist and care team

Expert Clinical Team
- Clinical pharmacists specializing in biologic therapies
- Experienced infusion nurses trained in MG-specific protocols
- Patient care coordinators managing scheduling and refills

At-Home Setting & Flexible Scheduling
- Peaceful setting in the comfort of your own home—not a hospital environment
- Flexible appointment times, including evenings and weekends

Insurance Support & Financial Assistance
- Full insurance verification and prior authorization handling
- Medicare and most major private insurance plans are accepted
- Financial assistance programs for qualifying patients
- Clear breakdown of copays before treatment begins
We accept Medicare and most major private insurance plans.
Call us to find out more about your coverage.
Testimonials
Service Area
AmeriPharma’s MG infusion services are available in 45+ states throughout the US. We are fully licensed and able to extend our services in the areas marked in blue on the map.

Frequently Asked Questions about Myasthenia Gravis
How long does a myasthenia gravis infusion take?
The duration of an infusion can vary depending on the specific medication being administered. Some biologic infusions may take 30 minutes to several hours, from catheter placement through completion and monitoring. Your infusion nurse will explain the expected timeframe before treatment begins and help you plan your day accordingly.
How often will I need infusion treatments?
The frequency of infusion treatments depends on the medication prescribed and your individual treatment plan. Some therapies are given weekly in cycles, while others may be administered every few weeks or months. Your neurologist and infusion care team will establish a schedule tailored to your condition and response to treatment.
How do I prepare my home for home infusion?
Preparing for home infusion is straightforward. Set up a clean, comfortable area with easy access to a table and chair or recliner where you can relax. Ensure that there is space for the nurse’s supplies and safe, clear access to an electrical outlet. Your infusion nurse will guide you on any specific steps you may need to follow before the first visit.
What happens if I have a reaction during the infusion?
Your infusion nurse will monitor you throughout the entire treatment and is trained to recognize and manage infusion reactions. If you experience any discomfort, changes in how you feel, or symptoms of a reaction, notify your nurse right away—they will take appropriate steps to ensure your safety and comfort.
Can I continue my other MG medications while receiving infusion therapy?
In most cases, patients continue their prescribed myasthenia gravis medications along with infusion therapy. Your neurologist will review your full treatment regimen and advise you on how to coordinate oral medications, injectables, and infusions safely. Always follow your provider’s instructions for medication timing and management.
Start Your Myasthenia Gravis Infusion Care Today
AmeriPharma® Specialty Care provides personalized myasthenia gravis infusion therapy with expert clinical support, insurance coordination, and a comfortable at-home experience. Get started today with a trusted specialty pharmacy that makes managing Myasthenia Gravis easier.
Resources
-

Medicare and TPN: What You Need To Know
Total parenteral nutrition (TPN) is a vital therapy for some…
-

TPN After Bariatric Surgery: Indications and Potential Side Effects
Though not routinely used after bariatric surgery, TPN (total parenteral…
-

TPN Central Line Care and Infection Prevention: A Patient’s Guide
If you or your loved one is receiving home infusion…
-

A Guide to Home Parenteral Nutrition for New Patients
Home parenteral nutrition (HPN) is an essential therapy for those…
-

Understanding Elevated Liver Enzymes Related to TPN Administration: Causes & Management
While TPN (total parenteral nutrition) can be life-saving for individuals…